Burnout, Lack of Job Satisfaction Driving Doctors to Cut Hours

This article originally appeared here.
Share this content:
Burnout, Lack of Job Satisfaction Driving Doctors to Cut Hours
Burnout, Lack of Job Satisfaction Driving Doctors to Cut Hours

WEDNESDAY, May 18, 2016 (HealthDay News) -- Full-time physicians reporting worsening burnout or decreased job satisfaction are more likely to reduce their work hours, according to a study published in the April issue of Mayo Clinic Proceedings.

The researchers used administrative/payroll records to assess the work status of faculty physicians working for Mayo Clinic from Oct. 1, 2008, to Oct. 1, 2014.

Based on a survey of 1,856 physicians, full-time physicians who report worsening burnout or show decreasing job satisfaction are more likely to reduce their working hours. For each one-point increase on a seven-point emotional exhaustion scale the likelihood of reducing full-time employment over the next 24 months was increased by 43 percent. Each one-point decrease in the five-point satisfaction score correlated with a 34 percent increased likelihood of reducing work hours.

"Among physicians in a large health care organization, burnout and declining satisfaction were strongly associated with actual reductions in professional work effort over the following 24 months," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Post-Deployment Screening Has Limited Benefit in U.K. Military

Post-Deployment Screening Has Limited Benefit in U.K. Military

Screening based on tailored advice does not reduce prevalence of disorders or increase help-seeking

Excess BMI Ups Risk of T1DM in Autoantibody-Positive Relatives

Excess BMI Ups Risk of T1DM in Autoantibody-Positive ...

Increased diabetes progression risk occurred at lower cumulative excess BMI index in children <12

Baricitinib Associated With Significant Improvement in RA

Baricitinib Associated With Significant Improvement in RA

Findings versus placebo, adalimumab in patients non-responsive to methotrexate

is free, fast, and customized just for you!

Already a member?

Sign In Now »